SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000878088-11-000077
Filing Date
2011-12-05
Accepted
2011-12-05 11:35:01
Documents
6
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A f10qa1june302011.htm 10-Q/A 17781
2 SHARE PURCHASE AGREEMENT sharepurchaseagmredactfor10q.htm EX-10.2 479240
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER exhibit31ceocerttoq210qa.htm EX-31.1 8548
4 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER exhibit31cfocerttoq210qa.htm EX-31.2 8571
5 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER exhibit32ceotoq210qa.htm EX-32.1 3476
6 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER exhibit32cfotoq210qa2011.htm EX-32.2 3804
  Complete submission text file 0000878088-11-000077.txt   522523
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-10827 | Film No.: 111242338
SIC: 2834 Pharmaceutical Preparations